Latest News and Press Releases

Philadelphia, PA, May 30, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, has appointed Vanessa Wolfeler as its new Chief Executive Officer (CEO) effective...

West Conshohocken, PA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, announces the presentation of the largest study to date of patients with high-dose methotrexate (HDMTX)...

West Conshohocken, PA, Sept. 21, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, announced today that SERB will present in vivo data for PR022, a polyclonal antibody in development as...

West Conshohocken, PA, June 22, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, highlights the recent updates to the National Comprehensive Cancer Network (NCCN) Guidelines for Acute...

West Conshohocken, PA, May 02, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, today announced the publication of a new analysis of data from the American College of Medical...

West Conshohocken, PA, March 15, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, today announces the publication of an economic simulation assessing the value of Voraxaze®...

Philadelphia, July 14, 2022 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals has signed a worldwide exclusive license to use an antigen from Soligenix [NSDQ: SNGX] to develop a novel therapeutic treatment...

Vienna, June 09, 2022 (GLOBE NEWSWIRE) -- The European Hematology Association (EHA) Conference published four independent studies of Voraxaze® (glucarpidase) by various investigators for inclusion...

Philadelphia, April 11, 2022 (GLOBE NEWSWIRE) -- SERB and BTG Specialty Pharmaceuticals are pleased to announce that Thomas Kolaras has been named the group’s new Chief Commercial Officer for its US...

Paris, April 04, 2022 (GLOBE NEWSWIRE) -- SERB is pleased to announce it has acquired the rights from Ipsen to commercialize Xermelo® (telotristat ethyl) in Europe and other countries outside the US...